Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity

Wenying Yang, Wenhui Zhao, Jianzhong Xiao, Rui Li, Ping Zhang, Katarzyna Kissimova-Skarbek, Erin Schneider, Weiping Jia, Linong Ji, Xiaohui Guo, Zhongyan Shan, Jie Liu, Haoming Tian, Li Chen, Zhiguang Zhou, Qiuhe Ji, Jiapu Ge, Gang Chen and Jonathan Brown

PLOS ONE, 2012, vol. 7, issue 9, 1-13

Abstract: Background: The Diabetes Impact Study followed up a large national population-based screening study to estimate the use of and expenditures for medical care caused by diabetes in China and to ascertain the use and cost of essential basic medicines and care. Methods: In 2009–10, the study team interviewed 1482 adults with diabetes and 1553 adults with glucose tolerance in the normal range from population-based random samples at 12 sites in China. The response rate was 67%. Findings: After adjusting for age, sex, and urban/rural location, people with diabetes received 1.93 times more days of inpatient treatment, 2.40 times more outpatient visits, and 3.35 times more medications than people with normal glucose tolerance (all p

Date: 2012
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0039513 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 39513&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0039513

DOI: 10.1371/journal.pone.0039513

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().